[Dihydrazaline (Depressan) treatment of eclampsia imminens and eclampsia].
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002585:Cesarean Section; D004359:Drug Therapy, Combination; D004461:Eclampsia / Q000188:drug therapy*; D005260:Female; D006571:Heterocyclic Compounds / Q000627:therapeutic use*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007226:Infant Mortality; D007275:Injections, Intravenous; D011225:Pre-Eclampsia / Q000188:drug therapy*; D011247:Pregnancy; D011724:Pyridazines / Q000627:therapeutic use*
D000927:Anticonvulsants; D000959:Antihypertensive Agents; D006571:Heterocyclic Compounds; D006834:Hydrazines; D011724:Pyridazines
Die Behandlung der Eclampsia imminens und der Eklampsie mit Dihydralazin (Depressan)